Jeffrey Kordower, PhD - Chair


Dr. Jeffrey H. Kordower is The Alla V. and Solomon Jesmer Professor of Neurological Sciences, Professor of Neurosurgery, Director, Research Center for Brain Repair, Section Head on Neuroscience, and Director of the Neuroscience Graduate Program at Rush University Medical Center, Professor of Neurodegeneration at the Van Andel Institute. He received his B.A. and MA from the CUNY and his Ph.D. from that same institution in 1984.  He received an Honorary Doctor of Science from CUNY in 2004. Dr. Kordower is an international authority in the area of aging movement disorders, which special expertise in experimental therapeutics and pathogenesis in movement disorders. His laboratory is particularly well known for studies in primates. In this regard, he has performed the critical preclinical studies required to translate experimental therapeutic into clinical trials.  In this regard, numerous gene and cell therapy preclinical studies that have been tested in patients with Parkinson’s disease.  Experimentally, he has published landmark papers in the area of cell replacement strategies including the first demonstration that fetal dopaminergic grafts can survive, innervate and form synapses in patients with Parkinson’s disease (NEJM). Furthermore, he demonstrated that long-term grafts in such patients can form Lewy bodies (Nature Medicine). He recently co-authored a paper in Nature demonstrating that of human dopaminergic stem cell can survive and function in parkinsonian mice, rats and monkeys (Nature). With regards to gene therapy, he published the lead article in Science demonstrating that gene delivery GDNF can prevent the emergence of motor symptoms and prevents nigrostriatal degeneration in nonhuman primate models of PD. He also was also the first to demonstrate that gene delivery of CNTF can obviate neurodegenerative processes in a nonhuman primate model of Huntington’s disease (Nature). Dr. Kordower has published close to 400 manuscripts and chapters, has lectured all over the world, has been on over 20 Journal Editorial boards (including Sections Head or Associate Editor on three; Journal of Comparative Neurology, Movement Disorders, and Neurobiology of Aging). He has also been the Past President of the American Society of Neural Transplantation (now American Society of Neural Therapy and Repair), served on the program committee for the World Parkinson’s Congress, and is both a founding SAB member, and past Executive Committee member, for the Michael J. Fox Foundation.

Richard Born, MD - Vice Chair


Richard T. Born, M.D., is a Professor of Neurobiology at Harvard Medical School and former (2009-2014) Director of the Harvard PhD Program in Neuroscience. He was raised in the Upper Peninsula of Michigan and attended DePauw University where he received a B.A. in Chemistry in 1983. He attended Harvard Medical School (HMS), where he discovered the joys of visual neurophysiology working with Professors David Hubel and Margaret Livingstone. After receiving the M.D. degree in 1988, he continued on as a postdoctoral fellow in the Hubel/Livingstone lab, undertook a second postdoc with William Newsome at Stanford and then returned to HMS in 1995 as an Assistant Professor in the Department of Neurobiology. He has remained at HMS ever since with the exception of a year-long sabbatical in 2005 at the CNRS in Toulouse, France. He became a Full Professor in 2006 and Director of the PhD Program in Neuroscience in 2009. His scientific work has been recognized with Fellowships from the Klingenstein, Whitehall, Kirsch and Lefler Foundations and the Jesse L. Sigelman Award for Innovation and Excellence. He recently (2014) received the Harvard Division of Medical Sciences Award for Exceptional Leadership in Graduate Education. His laboratory studies cortical visual processing in nonhuman primates, with a particular focus on the computational role of cortico-cortical feedback.

Kathryn Bayne, MS PhD, DVM, DACLAM, DACAW, CAAB


Dr. Bayne is Chief Executive Officer for AAALAC International, a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary assessment and accreditation programs.  Prior to this position she worked at the National Institutes of Health leading a research program on nonhuman primate psychological well-being and environmental enrichment programs for primates, dogs, cats and swine.   She is a Diplomate of the American College of Laboratory Animal Medicine and of the American College of Animal Welfare.  She is also a certified applied animal behaviorist and has published extensively in laboratory animal behavior and welfare. Dr. Bayne has held several leadership positions including service as President of the American College of Laboratory Animal Medicine, the Association of Primate Veterinarians, as well as the District of Columbia Veterinary Medical Association. She is past Chair of the American Veterinary Medical Association’s Animal Welfare Committee and was the inaugural Chair of the American Society of Laboratory Animal Practitioner’s Animal Welfare Committee. Dr. Bayne was the 2009 recipient of the American Veterinary Medical Association’s Animal Welfare Award and Washington State University’s 2009 Excellence in Research and Teaching Award. In 2012 she was awarded the Charles River Prize for her international efforts in advancing laboratory animal welfare.

Timothy M. Fan, DVM, PhD


Dr. Fan is an associate professor of the Department of Veterinary Clinical Medicine at the University of Illinois at Urbana-Champaign. After receiving his Doctor of Veterinary Medicine Degree at Virginia-Maryland Regional College of Veterinary Medicine in 1995, Dr. Fan trained in the clinical disciplines of Internal Medicine at Cornell University and Oncology at the University of Illinois. Following the completion of Dr. Fan’s clinical training, he pursued and completed a PhD in Tumor Immunology at the University of Illinois, whereby he investigated the anticancer effects of cytokine manipulation strategies for the treatment of locally-invasive and metastatic tumors in mouse models of disease. Upon completion of his PhD in 2007, Dr. Fan now serves as the principal investigator of the Comparative Oncology Research Laboratory housed in the Small Animal Clinic, Department of Veterinary Clinical Medicine. Dr. Fan’s laboratory works closely with other basic scientists for evaluating novel drugs or drug delivery strategies for the treatment of cancer. Uniquely, Dr. Fan’s training as a scientist and veterinarian, has allowed him the opportunity to rapidly investigate and translate novel treatment strategies in dogs with spontaneously-arising cancers, a

nd conduct meaningful comparative oncology research which is hoped to eventually aid in treating cancer in not only companion animals, but also human beings.

Gloria Gaito


Gloria Gaito is currently the Executive Director of Global Animal Welfare and Compliance for Comparative Medicine at Pfizer, Inc. In this role, she is responsible for oversight of the animal care and welfare programs across Pfizer, ensuring compliance with regulatory expectations and internal standards. She also handles internal and external communications on animal issues and monitors legislative and regulatory activity globally. In addition, Gloria is a member of Pfizer’s cross-divisional Animal Care and Welfare Board, which promotes humane research, advancement of the 3Rs, and a high standard of animal care and welfare in all of the company’s animal-based activities. Gloria is actively engaged in outreach and public education on the importance of biomedical research and our industry’s commitment to the care and welfare of research animals. She holds membership in several professional organizations covering the scope of laboratory animal science and welfare. Currently, Gloria serves on the Board of the New Jersey Association for Biomedical Research and is a member of the IQ Consortium’s 3R Leadership Group. Gloria received her undergraduate degree in Laboratory Animal Science from Quinnipiac University. She earned her Master’s of Business Administration degree from the University of Rhode Island in the Executive Master of Business Administration program and her Master of Science degree in Quality Assurance/Regulatory Affairs from Temple University.

Scott Marshall


Scott Marshall is President and CEO of Marshall BioResources (MBR), a global provider of purpose-bred animals and related services for biomedical research.  MBR is headquartered in North Rose, New York, and has production facilities in the U.S., Europe and China.  MBR’s primary animal models are canines, ferrets and minipigs.  Scott has been with this family-owned business since 1991 and has served as President and CEO since 2003. Scott was a founding Director of the European Animal Research Association (EARA), established in 2013.  He currently serves on the Board of Directors of the New Jersey Association for Biomedical Research (NJABR), the Research Advisory Committee for the Associated Medical Schools of New York (AMSNY), and as an affiliated member of the ACLAM Task Force on Research Animal Transportation.  In his community, Scott is a longtime board member of the Golisano Children’s Hospital at the University of Rochester Medical Center.  He also was a longtime board member of the Newark-Wayne Community Hospital Foundation and served as its Chairman from 2014-2016. Scott received a B.S. degree from the Dyson School of Applied Economics and Management at Cornell University and holds an M.B.A. degree from the Simon Business School at the University of Rochester.  Scott, his wife, and their four children reside near Rochester, New York.

Ross McKinney, MD


Dr. Ross McKinney currently serves as chief scientific officer of the Association of American Medical Colleges (AAMC), a position to which he was appointed in September 2016. Prior to joining the AAMC, Dr. McKinney spent more than three decades as a faculty member at the Duke University School of Medicine.  He graduated from Dartmouth College in 1975, and received his MD degree from the University of Rochester School of Medicine and Dentistry in 1979.  Dr. McKinney did his pediatric residency and pediatric infectious diseases fellowship at Duke, and joined the Duke faculty in 1985.  At Duke, he rose through the ranks, eventually achieving the academic rank of Professor of Pediatrics.  From 1994 to 2003 he served as chief of the division of Pediatric Infectious Diseases, and 2002 he was appointed the Vice Dean for Research in the School of Medicine. In this role, he was an instrumental member of the team responsible for securing an NIH Clinical and Translational Science Award (CTSA) at Duke in 2007, one of the first institutions so awarded. Dr. McKinney later served as chair of the Clinical Research Ethics Key Function Committee of the NIH CTSA collaborative consortium.  In 2007 he switched roles at Duke and became the director of the Trent Center for Bioethics, Humanities and History of Medicine, a position he held until 2016 when he moved to the AAMC. Dr. McKinney’s research was on the treatment of children with HIV infection, with parallel work in the natural history of pediatric HIV disease and the prevention of mother-to-child HIV transmission.  At the Trent Center, he worked on the ethics of human subjects research, informed consent, and the nature of conflicts of interest in research.

Guy Mulder, DVM, MS, MBA, DACLAM


Dr. Mulder is the Executive Director of Veterinary and Professional Services for Charles River Research Models and Services. His responsibilities include regulatory, technical, and biosecurity oversight of commercial rodent and rabbit production and surgical services. Dr. Mulder is active in numerous professional organizations including American Association for Laboratory Animal Science, American College of Laboratory Animal Medicine, American Society of Laboratory Animal Practitioners, the North America Laboratory Animal Breeders Association, International Air Transit Association, and he serves as an ad hoc site visitor with AAALAC, International. Prior to joining Charles River Laboratories, Dr. Mulder was Director and Attending Veterinarian for University Laboratory Animal Resources at the University of California, Irvine.  Before entering the field of laboratory animal medicine, Dr. Mulder practiced small animal medicine in Seattle, Washington. Dr. Mulder is a Diplomate of the American College of Laboratory Animal Medicine.  He completed postdoctoral training and received his Master of Science degree in Comparative Medicine from the University of Washington, his DVM degree from Washington State University, his MBA degree from Suffolk University, and his Bachelor of Science degree from Willamette University.

John Norton, DVM, PhD, DABT, DACLAM


Dr. Norton serves as the Director of the Division of Laboratory Animal Resources and is a Professor of Pathology at Duke University as well as an Adjunct Professor of Clinical Sciences at North Carolina State University College of Veterinary Medicine.  He also serves as the Director of Preclinical Toxicology at Duke University.  He is board-certified through the American College of Laboratory Animal Medicine (ACLAM) and the American Board of Toxicology (ABT). He holds bachelor degrees in biochemistry and animal science as well as a doctorate in veterinary medicine from North Carolina State University. Additionally, his Ph.D. in pharmacology was awarded from Vanderbilt University.  Dr. Norton has over 25 years of laboratory animal medicine and research experience including serving as Study Director and/or Manager in over 150 preclinical pharmacology and safety studies. He regularly attends national and regional continuing education provisions for maintenance of credentials and for professional development and is active in numerous professional organizations.  His collaborative research focuses on extrinsic factors which may influence the animal research model, specifically in the area of noise and vibration.

Mark Rasenick, PhD


Dr. Rasenick’s work has focused on G protein signaling in the nervous system and the relationship of neurotransmitter activation to rapid modification of the cytoskeleton.  He has been particularly interested in how G proteins and the cytoskeleton work in concert to modify synaptic shape and to form a molecular basis for depression and the action of antidepressant drugs.  The most recent work from his group suggests the possibility of a simple blood test indicating depression and therapeutic response to antidepressant therapy. This has led to the creation of Pax Neuroscience, which recently received SBIR funding from NIMH. Dr. Rasenick’s research continues to be funded by the NIH, the Veterans Administration, as well as by other government, philanthropic and industry sources.  He is principal investigator of an NIMH training grant, “Training in the Neuroscience of Mental Health”, which supports graduate students and postdoctoral fellows in the neurosciences.  He is also the co-founder of UIC’s Graduate Program in Neuroscience.  He has served on many scientific review panels (NIH, NSF, DOD), and editorial boards and is the author of numerous publications.  Dr. Rasenick has received honors both for teaching and research, including the Searle Young Faculty Award from the Chicago Community Trust, the University Scholar Award and Distinguished Faculty Award from the University of Illinois, a Research Scientist Award from the NIMH, and a Robert Wood Johnson Health Policy Fellowship from the Institute of Medicine/National Academy of Sciences.  He is an elected fellow of the American College of Neuropsychopharmacology and the American Association for the Advancement of Science and an elected member of the Dana Alliance for Brain Research and the Cuban Academy of Science. In addition to research and teaching, Dr. Rasenick is active in public policy.  He served as a member of the Commission on Social Action of Reform Judaism and the Chapters committee and Government and Public Affairs Committee and International Affairs Committee of the Society for Neuroscience.  He also serves or has served on the Public Affairs/Outreach committees of the American Society for Biochemistry and Molecular Biology and the American College of Neuropsychopharmacology, and chaired that Committee for ACNP. He currently chairs the Advocacy Committees for the American Brain Coalition and for the National Network of Depression Centers.

Charles Roberts, PhD


Charles Roberts, Ph.D., is Associate Director for Research and Professor in the Divisions of Cardiometabolic Health and Developmental and Reproductive Sciences at the Oregon National Primate Research Center (ONPRC) and Professor of Medicine, Pediatrics, and Cell, Developmental, and Cancer Biology at Oregon Health & Science University (OHSU).  Dr. Roberts was previously Assistant Research Professor of Biochemistry and Molecular Biology at the University of California, Santa Barbara (1978-1984), Senior Investigator in the Diabetes Branch of the National Institute of Diabetes and Digestive and Kidney Diseases at the NIH (1984-1994), and Associate Chair for Research and Chief of the Division of Pediatric Research in the Department of Pediatrics at OHSU (1994-2007).  Dr. Roberts is also co-founder, vice-president, and chief science officer for DiabetOmics, Inc., in Hillsboro, OR, a diagnostics development firm in the areas of diabetes and fetal-maternal health. Dr. Roberts' contributions to the national biomedical research enterprise include participation in over 50 grant review panels for the NIH, the VA, and the DOD, membership on the editorial boards of Endocrinology and the Journal of Biological Chemistry as well as ad hoc reviewing for 60 other journals, and committee service for the Endocrine Society. Dr. Roberts is a molecular endocrinologist with a long-standing interest in growth factor and insulin action.  His previous work employed a variety of experimental models, including human cell systems and rodent models, to investigate mechanisms of metabolic control and cancer.  Dr. Roberts' current research at the ONPRC utilizes nonhuman primate models of obesity, diabetes, polycystic ovary syndrome and maternal malnutrition to assess disease mechanism and potential therapeutic interventions.  These studies are supported by NIH, pharma, and philanthropic funding.

David Schabdach, DVM, DACLAM


David Schabdach is the Attending Veterinarian and Sr. Executive Director of the Division of Laboratory Animal Resources at the University of Pittsburgh.  He received his DVM from the Virginia-Maryland College of Veterinary Medicine, MS in Laboratory Animal Medicine from the Pennsylvania State University, and is a Diplomate of the American College of Laboratory Medicine.  David spent three years in private practice prior to entering the field of laboratory animal medicine where he has worked for the past 28 years in both large pharma and academia.  Dr. Schabdach serves on the Council for Accreditation for AAALAC International, the Board of Directors for the Pennsylvania Society for Biomedical Research, and as the IACUC chairperson for the American Veterinary Medical Association.

Ann Turner PhD, FASAE, CAE


With over 40 years of experience in association management, health care administration, and education, Dr. Ann Turner has served her communities in various manners. She is currently the executive director of the American Association for Laboratory Animal Science (AALAS) in Memphis, TN.  Prior to her current position, she served in various capacities for healthcare, rehabilitation and educational associations.  She began her career in the educational arena and has taught and conducted research at the secondary school and university levels as well worked in community-based services and adult continuing education programs.  Dr. Turner earned a bachelor’s degree from the University of Tennessee, a Master of Education from the Pennsylvania State University, and a Doctor of Philosophy in Community Systems Planning and Development also from Penn State.  Dr. Turner has been a Certified Association Executive (CAE) since 1989 and was awarded Fellow status in the American Society of Association Executives (ASAE)in 2006. She served on the Board of Directors for ASAE and the ASAE Foundation 2011 – 2013 and currently serves on the ASAE 2020 Centennial Research Initiative Task Force.  Ann served as a community member of the University of Tennessee Health Sciences Center IACUC from 2006 - 2016. She has published in scholarly journals as well as practice-oriented publications and is a frequent speaker on association administration, leadership, management, professional development and strategic planning. She currently serves as Chair of the Elders in her church and sings in the church sanctuary choir.

Sherry Vaughn, DVM


Sherry has been fortunate to live her passion during a lengthy career.  Her love of animals, animal science, and biology led her to complete a Bachelor of Science at New Mexico State University, and later a Doctor of Veterinary Medicine from Colorado State University (1982). Working with animals and people in private veterinary practice, emergency practice, academia, the pharmaceutical and animal health industry has taken Sherry from Colorado to New Mexico to Connecticut to Michigan.  She has worked with pet animals, equines, reptiles, farm animals, non-human primates, chimpanzees and laboratory animals.  Her current position is at Zoetis, one of the largest animal health companies. Zoetis works to make the job of veterinarians, pet owners, and livestock producers, easier.  As a veterinarian, Sherry’s job feels like a career “home”.  Her Associate Director role as the global lead for animal welfare compliance has taken her from North America to South American to Europe and Asia.  Her position focuses on helping to improve the lives of research animals by adopting the most humane practices, promoting the 3Rs, and enhancing a culture of caring.  Sherry’s passions continue to be animal health, veterinary science, and ethics.”

Wanda West, DVM, PhD, DACLAM


Dr. Wanda L. West has over 25 years of experience as a board-certified laboratory animal veterinarian. She is currently the Director and Attending Veterinarian for Boehringer Ingelheim Pharmaceuticals, Inc. located in Ridgefield, CT and she also serves as the Global Animal Welfare Officer for Human Pharma Innovation Unit. Dr. West previously worked in various roles up to the Associate Director level at DuPont Pharmaceuticals Company, Wilmington, DE and as a Veterinary Research Fellow at Bristol-Myers Squibb Biopharmaceutical Company, Princeton, NJ.  Dr. West earned her Doctor of Veterinary Medicine degree from Mississippi State University, Miss. State, MS. She completed a Small Animal Medicine and Surgery Internship at North Carolina College of Veterinary Medicine, Raleigh, NC and completed a three-year residency program in Laboratory Animal Medicine at University of Illinois at Chicago, Chicago, IL.  Dr. West also earned a Doctor of Philosophy degree in Pharmacology with a specialization in Neuroscience from Temple University School of Medicine, Philadelphia, PA.  Dr. West has been a Diplomate in the American College of Laboratory Animal Medicine since 1994. Wanda has served on several ASLAP and ACLAM committees during her career, including an appointment on the ASLAP Board of Directors during 2009-2012, and serving as President during 2013-14. Dr. West has a passion for education and is a lecturer at Drexel University teaching courses in the Master of Laboratory Animal Science Program. She has also taught laboratory animal courses at the University of Pennsylvania. Wanda has served as a thesis advisor for students at Thomas Jefferson University and Drexel University. Dr. West has recently accepted an appointment on a newly formed Dean’s Advisory Board at Mississippi State University College of Veterinary Medicine. She has published several peer-reviewed journal articles and book chapters, and she currently is a reviewer for JAALAS and Jove. Her other professional interests include neuropharmacology, pain management, and surgical model development.